EZZ Life Science Holdings Ltd (EZZ) — Capital Reinvestment Ratio
Latest as of June 2025:
0.02x
EZZ Life Science Holdings Ltd (EZZ) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$2.86 Million) in capital expenditures (AU$48.35K). See EZZ free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
AU$2.86 Million
AUD
Capital Expenditures
AU$48.35K
AUD
Data as of
Jun 2025
Most recent filing
EZZ Life Science Holdings Ltd Capital Reinvestment Ratio (2018–2024)
This chart tracks EZZ Life Science Holdings Ltd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for EZZ Life Science Holdings Ltd (2018–2024)
Year-by-year Capital Reinvestment Ratio for EZZ Life Science Holdings Ltd from 2018 to 2024. For live market cap and broader valuation context, see EZZ Life Science Holdings Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | AU$4.35 Million | AU$260.88K | ▼ -10.0% |
| 2023 | 0.07x | AU$6.14 Million | AU$409.29K | ▲ +162.7% |
| 2022 | 0.03x | AU$4.01 Million | AU$101.78K | ▲ +266.0% |
| 2021 | 0.01x | AU$1.90 Million | AU$13.18K | ▼ -89.1% |
| 2020 | 0.06x | AU$253.53K | AU$16.12K | ▲ +107.3% |
| 2019 | 0.03x | AU$2.97 Million | AU$91.20K | ▲ +402.0% |
| 2018 | 0.01x | AU$416.33K | AU$2.54K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow